__timestamp | Incyte Corporation | Zoetis Inc. |
---|---|---|
Wednesday, January 1, 2014 | 347523000 | 396000000 |
Thursday, January 1, 2015 | 479514000 | 364000000 |
Friday, January 1, 2016 | 581861000 | 376000000 |
Sunday, January 1, 2017 | 1326361000 | 382000000 |
Monday, January 1, 2018 | 1197957000 | 432000000 |
Tuesday, January 1, 2019 | 1154111000 | 457000000 |
Wednesday, January 1, 2020 | 2215942000 | 463000000 |
Friday, January 1, 2021 | 1458179000 | 508000000 |
Saturday, January 1, 2022 | 1585936000 | 539000000 |
Sunday, January 1, 2023 | 1627594000 | 614000000 |
Monday, January 1, 2024 | 2606848000 | 686000000 |
Unleashing the power of data
In the competitive landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Incyte Corporation and Zoetis Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Incyte Corporation's R&D expenses surged by over 360%, peaking in 2020. This substantial increase underscores Incyte's aggressive pursuit of new therapies and market expansion. Notably, their R&D spending in 2023 was nearly three times that of Zoetis Inc., highlighting their focus on innovation.
Zoetis Inc., a leader in animal health, has maintained a steady increase in R&D spending, growing by approximately 55% over the same period. Their strategic investments reflect a balanced approach, ensuring sustainable growth while maintaining profitability.
These spending patterns reveal distinct corporate strategies, offering insights into each company's future trajectory.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
Cost Management Insights: SG&A Expenses for Zoetis Inc. and Incyte Corporation
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Incyte Corporation vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Incyte Corporation vs Mesoblast Limited: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.